EGFR mutant-selective inhibitor WZ4002
Term · Oncology and biomedicine · MLC-T-ONC-013263
An inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. Upon administration, EGFR mutant-selective inhibitor WZ4002 specifically targets, binds to and inhibits EGFR T790M, which prevents EGFR T790M mutant-mediated signaling and leads to cell death in EGFR T790M mutant-expressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.
| Identifier | MLC-T-ONC-013263 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | EGFR T790M inhibitor WZ4002 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013263",
"term": "EGFR mutant-selective inhibitor WZ4002",
"field": "Oncology and biomedicine",
"definition": "An inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. Upon administration, EGFR mutant-selective inhibitor WZ4002 specifically targets, binds to and inhibits EGFR T790M, which prevents EGFR T790M mutant-mediated signaling and leads to cell death in EGFR T790M mutant-expressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.",
"synonyms": [
"EGFR T790M inhibitor WZ4002"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/egfr-mutant-selective-inhibitor-wz4002/"
}
Record 6,455 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.